ADAM23 in Cardiomyocyte Inhibits Cardiac Hypertrophy by Targeting FAK‐AKT Signaling

BACKGROUND: Cardiac hypertrophy has been recognized as an important independent risk factor for the development of heart failure and increases the risk of cardiac morbidity and mortality. A disintegrin and metalloprotease 23 (ADAM23), a member of ADAM family, is involved in cancer and neuronal diffe...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Am Heart Assoc
Autors principals: Xiang, Mei, Luo, Hongbo, Wu, Jia, Ren, Lingyun, Ding, Xiangchao, Wu, Chuangyan, Chen, Jiuling, Chen, Shanshan, Zhang, Hao, Yu, Lu, Zou, Yanqiang, Xu, Heng, Ye, Ping, Chen, Manhua, Xia, Jiahong
Format: Artigo
Idioma:Inglês
Publicat: John Wiley and Sons Inc. 2018
Matèries:
Original Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6222933/
https://ncbi.nlm.nih.gov/pubmed/30371220
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/JAHA.118.008604
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars